Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

iSpecimen (ISPC) Cost of Revenue: 2020-2025

Historic Cost of Revenue for iSpecimen (ISPC) over the last 6 years, with Sep 2025 value amounting to $1.1 million.

  • iSpecimen's Cost of Revenue fell 26.59% to $1.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.6 million, marking a year-over-year decrease of 34.02%. This contributed to the annual value of $5.3 million for FY2024, which is 10.01% up from last year.
  • As of Q3 2025, iSpecimen's Cost of Revenue stood at $1.1 million, which was up 156.86% from $444,177 recorded in Q2 2025.
  • In the past 5 years, iSpecimen's Cost of Revenue ranged from a high of $1.6 million in Q1 2021 and a low of $444,177 during Q2 2025.
  • In the last 3 years, iSpecimen's Cost of Revenue had a median value of $1.1 million in 2023 and averaged $1.1 million.
  • Per our database at Business Quant, iSpecimen's Cost of Revenue spiked by 127.61% in 2021 and then plummeted by 68.82% in 2025.
  • Quarterly analysis of 5 years shows iSpecimen's Cost of Revenue stood at $1.2 million in 2021, then grew by 15.32% to $1.4 million in 2022, then climbed by 1.25% to $1.4 million in 2023, then fell by 7.22% to $1.3 million in 2024, then decreased by 26.59% to $1.1 million in 2025.
  • Its last three reported values are $1.1 million in Q3 2025, $444,177 for Q2 2025, and $657,279 during Q1 2025.